Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
SELL
29 Mar 2023Roberts William T.
Chief Accounting Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
7,872-10%
912
$17.50
$15,960.00
SELL
14 Feb 2023Mazabraud Yann
EVP, Head of International, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
3,827-23%
1,177
$27.03
$31,814.31
SELL
11 Feb 2023Shulman Joseph
Chief Technical Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
3,741-12%
554
$26.87
$14,885.98
SELL
11 Feb 2023Chien Jennifer
EVP, Head of North America, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,940-11%
635
$26.87
$17,062.45
SELL
11 Feb 2023Smith Hunter C
Chief Financial Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
59,406-1%
702
$26.87
$18,862.74
SELL
9 Feb 2023Cramer Pamela J.
Chief Human Resources Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
6,151-11%
834
$27.66
$23,068.44
SELL
9 Feb 2023Shulman Joseph
Chief Technical Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,742-25%
921
$27.66
$25,474.86
SELL
9 Feb 2023Smith Hunter C
Chief Financial Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
57,779-2%
1,398
$27.66
$38,668.68
SELL
9 Feb 2023Mazabraud Yann
EVP, Head of International, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,988-34%
1,548
$27.66
$42,817.68
SELL
9 Feb 2023Roberts William T.
Chief Accounting Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
6,294-13%
959
$27.66
$26,525.94
SELL
9 Feb 2023Chien Jennifer
EVP, Head of North America, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
3,556-25%
1,192
$27.66
$32,970.72
SELL
9 Feb 2023Smith Hunter C
Chief Financial Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
57,764-2%
1,413
$27.51
$38,871.63
SELL
9 Feb 2023Chien Jennifer
EVP, Head of North America, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
3,544-25%
1,204
$27.51
$33,122.04
SELL
9 Feb 2023Shulman Joseph
Chief Technical Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,732-25%
931
$27.51
$25,611.81
SELL
9 Feb 2023Mazabraud Yann
EVP, Head of International, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,973-34%
1,563
$27.51
$42,998.13
SELL
9 Feb 2023Roberts William T.
Chief Accounting Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
6,284-13%
969
$27.51
$26,657.19
SELL
9 Feb 2023Cramer Pamela J.
Chief Human Resources Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
6,142-12%
843
$27.51
$23,190.93
SELL
19 Aug 2022Cramer Pamela J.
Chief Human Resources Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,224-85%
13,493
$24.83
$335,031.20
SELL
26 Jul 2022Cramer Pamela J.
Chief Human Resources Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,224-28%
901
$11.68
$10,523.68
SELL
30 Jun 2022Smith Hunter C
Chief Financial Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
57,614-11%
7,547
$4.08
$30,791.76
SELL
29 Mar 2022Roberts William T.
Chief Accounting Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
1,477-40%
1,023
$11.13
$11,385.99
SELL
11 Feb 2022Smith Hunter C
Chief Financial Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
40,161-2%
833
$6.10
$5,081.30
SELL
11 Feb 2022Mazabraud Yann
EVP, Head of International, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
1,098-45%
934
$6.10
$5,697.40
SELL
11 Feb 2022Shulman Joseph
Chief Technical Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
1,006-35%
557
$6.10
$3,397.70
SELL
11 Feb 2022Chien Jennifer
EVP, Head of North America, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
1,310-35%
722
$6.10
$4,404.20
BUY
30 Mar 2021Meeker David P
President and CEO, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
111,335+9%
10,000
$20.17
$201,713.02
SELL
15 Mar 2021Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
909,258-52%
1,000,000
$25.10
$25,100,000.00
SELL
2 Dec 2020RA CAPITAL MANAGEMENT, L.P.
Former 10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,557,882-4%
238,543
$29.47
$7,029,652.50
SELL
31 Aug 2020Desikan Nithya
Chief Commercial Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
43,602-36%
25,000
$30.00
$750,000.00
SELL
30 Jun 2020RA CAPITAL MANAGEMENT, L.P.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
5,140,408-2%
131,581
$22.06
$2,902,517.20
SELL
26 Jun 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
1,909,258-0%
300
$25.04
$7,512.00
SELL
25 Jun 2020RA CAPITAL MANAGEMENT, L.P.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
5,271,989-2%
150,323
$23.05
$3,465,614.50
SELL
24 Jun 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
1,909,558-5%
115,335
$25.35
$2,923,845.20
SELL
5 Jun 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,024,893-0%
1,896
$20.00
$37,920.00
SELL
1 Jun 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,026,789-2%
44,358
$20.21
$896,511.90
SELL
27 May 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,071,147-1%
29,300
$20.17
$590,958.10
SELL
21 May 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,100,447-4%
96,921
$20.32
$1,969,194.00
SELL
18 May 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,197,368-1%
34,509
$20.00
$690,285.25
SELL
13 May 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,231,877-0%
1,837
$20.04
$36,813.48
SELL
8 May 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,233,714-2%
53,130
$20.25
$1,076,063.00
SELL
6 May 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,286,844-0%
1,826
$20.00
$36,522.00
SELL
28 Apr 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,288,670-1%
36,223
$20.10
$728,015.50
SELL
31 Mar 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,324,893-1%
34,570
$15.13
$523,153.50
SELL
26 Mar 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,359,463-0%
2,300
$15.04
$34,592.00
SELL
20 Mar 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,361,763-0%
1,100
$15.00
$16,500.00
SELL
17 Mar 2020Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,362,863-1%
30,634
$15.11
$463,031.70
SELL
27 Dec 2019Desikan Nithya
Chief Commercial Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
29,068-54%
35,181
$22.79
$801,771.44
SELL
11 Dec 2019Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,393,497-0%
17,362
$25.11
$435,991.62
SELL
9 Dec 2019Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,410,859-2%
64,034
$25.25
$1,616,800.00
SELL
2 Dec 2019Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,474,893-1%
42,143
$22.15
$933,443.40
SELL
26 Nov 2019Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,517,036-4%
127,544
$23.11
$2,947,317.00
SELL
22 Nov 2019Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,694,900-7%
224,025
$22.53
$5,047,557.00
SELL
20 Nov 2019Foley Todd
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,874,062-6%
206,288
$21.56
$4,446,998.00
SELL
30 May 2019Van der Ploeg Leonardus H.T.
Chief Scientific Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
42,339-19%
10,000
$25.21
$252,050.00
SELL
28 May 2019Van der Ploeg Leonardus H.T.
Chief Scientific Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
42,339-26%
15,000
$25.42
$381,350.00
SELL
15 Mar 2019Gottesdiener Keith Michael
CEO & President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
506,342-1%
10,290
$30.09
$309,647.28
SELL
13 Mar 2019Gottesdiener Keith Michael
CEO & President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
516,632-1%
9,288
$30.06
$279,182.22
SELL
26 Feb 2019Gottesdiener Keith Michael
CEO and President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
525,617-0%
2,449
$30.04
$73,570.69
SELL
15 Feb 2019Gottesdiener Keith Michael
CEO and President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
528,066-2%
12,920
$30.02
$387,885.94
SELL
13 Feb 2019Gottesdiener Keith Michael
CEO and President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
540,986-0%
3,934
$30.00
$118,020.00
SELL
22 Jan 2019Gottesdiener Keith Michael
CEO and President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
544,920-2%
15,779
$30.05
$474,175.75
SELL
18 Jan 2019Gottesdiener Keith Michael
CEO & President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
560,699-1%
10,115
$30.01
$303,551.16
SELL
16 Jan 2019Gottesdiener Keith Michael
CEO & President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
570,814-0%
662
$30.00
$19,860.00
SELL
16 Jan 2019Van der Ploeg Leonardus H.T.
Chief Scientific Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
42,339-0%
200
$30.00
$6,000.00
SELL
3 Dec 2018Gottesdiener Keith Michael
CEO and President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
571,476-0%
563
$30.00
$16,890.00
SELL
2 Nov 2018Gottesdiener Keith Michael
CEO and President, Director, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
572,039-2%
16,500
$30.08
$496,320.00
SELL
2 Nov 2018Van der Ploeg Leonardus H.T.
Chief Scientific Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
42,539-47%
38,000
$30.09
$1,143,420.00
SELL
25 Sep 2018Van der Ploeg Leonardus H.T.
Chief Scientific Officer, Officer
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
80,453-28%
31,800
$29.80
$947,540.00
SELL
22 May 2018ORBIMED ADVISORS LLC
10% Owner, See Remarks
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,751,679-0%
19,580
$30.43
$595,768.40
SELL
18 May 2018ORBIMED ADVISORS LLC
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,769,659-4%
131,636
$30.88
$4,065,439.80
BUY
10 Oct 2017NEW ENTERPRISE ASSOCIATES 13 LP
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,909,956+12%
550,000
$17.00
$9,350,000.00
BUY
10 Oct 2017MPM BIOVENTURES V, L.P.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,696,392+3%
100,000
$17.00
$1,700,000.00
BUY
10 Oct 2017BARRIS PETER J
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,909,956+12%
550,000
$17.00
$9,350,000.00
BUY
10 Oct 2017MOTT DAVID M
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,909,956+12%
550,000
$17.00
$9,350,000.00
BUY
10 Oct 2017Flynn James E
10% Owner, Possible Member of 10% Group
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
468,505+312%
355,000
$17.00
$6,035,000.00
BUY
10 Oct 2017Meeker David P
Director
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
101,335+32%
25,000
$17.00
$425,000.00
BUY
10 Oct 2017SANDELL SCOTT D
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,909,956+12%
550,000
$17.00
$9,350,000.00
BUY
10 Oct 2017KERINS PATRICK J
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,909,956+12%
550,000
$17.00
$9,350,000.00
BUY
10 Oct 2017Viswanathan Ravi
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,909,956+12%
550,000
$17.00
$9,350,000.00
BUY
10 Oct 2017ORBIMED ADVISORS LLC
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,901,295+13%
355,000
$17.00
$6,035,000.00
BUY
10 Oct 2017BASKETT FOREST
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,909,956+12%
550,000
$17.00
$9,350,000.00
BUY
10 Oct 2017Ipsen, S.A.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
833,099+2%
20,000
$17.00
$340,000.00
BUY
10 Oct 2017BARRETT M JAMES
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
4,909,956+12%
550,000
$17.00
$9,350,000.00
BUY
10 Oct 2017Foley Todd
Director, 10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
2,696,392+3%
100,000
$17.00
$1,700,000.00
BUY
10 Oct 2017PFIZER INC
10% Owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
1,427,639+2%
40,000
$17.00
$680,000.00
BUY
5 Oct 2017BAKER BROS. ADVISORS LP
Former 10% owner
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
170,778+123%
885,000
$17.00
$15,045,000.00